This Large Institutional Cancer Center is one of the world’s leading cancer
treatment and research institutions. This multi-phase project involved
the renovation of 10 unique pharmacy locations across the Houston
and Sugar Land campuses, all with the goal of bringing each space into
full compliance with USP 797 and USP 800 standards governing the
safety and quality of compounded and hazardous drug preparation
environments.
What began as targeted upgrades evolved into a full-scale replacement
of MEP infrastructure across the pharmacy portfolio. Telios leveraged a
rare extended shutdown period to modernize systems and improve longterm
reliability. Upgrades included new lighting, Phoenix control valves,
ductwork, and fan filter units, along with a redesigned airflow strategy to
deliver uniform, highly filtered supply air across the ceilings. Additional
low return and exhaust grilles were introduced to enhance sweeping
airflow patterns and improve particulate capture and removal. The Sugar
Land Pharmacy required replacement of the packaged rooftop unit and
hazardous exhaust fans. Pharmacies G7/9 and G14 received supplemental
air handling units to meet Owner Design Guideline space conditions that
exceeded USP 797/800 requirements alone.
Each location presented its own set of constraints, and the phased,
sequential nature of the project required close coordination to keep
operational disruptions to a minimum across an active cancer care
campus.
